RadNet (RDNT:NASDAQ) Investor Relations Material

Overview

Radiology services provider RadNet, Inc. is making strides in the application of artificial intelligence (AI), with a new division dedicated to developing AI solutions for breast, lung, and prostate cancer screenings. The firm, which also distributes, displays, stores and retrieves digital medical images, operates outpatient imaging centers across the United States. Its services include a range of diagnostic imaging procedures such as magnetic resonance imaging, computed tomography, and nuclear medicine, among others. RadNet has been working to enhance its radiologists' interpretations of images, and the company's latest efforts in AI are expected to further improve the accuracy of its cancer screenings. Founded in 1981, RadNet is headquartered in Los Angeles, California.

Frequently Asked Questions

What is RadNet's ticker?

RadNet's ticker is RDNT

What exchange is RadNet traded on?

The company's shares trade on the NASDAQ stock exchange

Where are RadNet's headquarters?

They are based in Los Angeles, California

How many employees does RadNet have?

There are 5001-10,000 employees working at RadNet

What is RadNet's website?

It is radnet.com

What type of sector is RadNet?

RadNet is in the Healthcare sector

What type of industry is RadNet?

RadNet is in the Medical Laboratories & Research industry

Who are RadNet's peers and competitors?

The following five companies are RadNet's industry peers:

- Invitae

- Heartbeam Inc

- Fluidigm Corporation

- Cytosorbents

- Psychemedics Corp.